RespireRx Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This report of RespireRx Pharmaceuticals Inc uses information from across the web as well as from public filings by RespireRx Pharmaceuticals Inc. This webpage of RespireRx Pharmaceuticals Inc was assembled by All Street Sevva using proprietary artificial intelligence. This page contains a questions and answers section on RespireRx Pharmaceuticals Inc.
RespireRx Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.4; made up of an environmental score of 8.0, social score of 1.6 and governance score of 6.7.
5.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 835 | Wuhan Keqian Biology Co Ltd | 5.5 | High |
| 835 | dorsaVi Ltd | 5.5 | High |
| 886 | RespireRx Pharmaceuticals Inc | 5.4 | High |
| 886 | Avant Brands Inc | 5.4 | High |
| 886 | Antengene Corporation Ltd | 5.4 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does RespireRx Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid RespireRx Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas RespireRx Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs RespireRx Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes RespireRx Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes RespireRx Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for RespireRx Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. It has two drug platforms comprising ResolutionRx, a pharmaceutical cannabinoids platform, which includes dronabinol that acts upon the CB1 and CB2 endocannabinoid receptors for use in chemotherapy-induced nausea and vomiting, as well as for anorexia in patients with AIDS and obstructive sleep apnea; and EndeavourRx, a neuromodulators platform that comprises AMPAkines program, including proprietary compounds that are positive allosteric modulators (PAMs) of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors to promote neuronal function, and GABAkines program, including proprietary compounds that are PAMs of GABAA receptors. The company's lead ampakine, CX1739, which has completed Phase II clinical studies for opioid-induced respiratory depression, as well as for central sleep apnea. It is also developing CX717, CX1739, and CX1942 that have clinical application in the treatment of CNS-driven neurobehavioral and cognitive disorders, spinal cord injury, neurological diseases, and various orphan indications. The company was formerly known as Cortex Pharmaceuticals, Inc. and changed its name to RespireRx Pharmaceuticals Inc. in December 2015. RespireRx Pharmaceuticals Inc. was incorporated in 1987 and is headquartered in Glen Rock, New Jersey.